Search

Author/Creator Pell, Robert

3. Greater utility of molecular subtype rather than epithelial‐to‐mesenchymal transition (EMT) markers for prognosis in high‐risk non‐muscle‐invasive (HGT1) bladder cancer. (6th May 2020)

Authors:
Ottley, Edward C; Pell, Robert; Brazier, Benedict; Hollidge, Julianne; Kartsonaki, Christiana; Browning, Lisa; O'Neill, Eric; Kiltie, Anne E
Journal:
Journal of pathology
Issue:
Volume 6:Number 4(2020)
Page Start:
238
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The important role of the histopathologist in clinical trials: challenges and approaches to tackle them. Issue 7 (30th May 2020)

Authors:
Provenzano, Elena; Driskell, Owen J; O'Connor, Daniel J; Rodriguez‐Justo, Manuel; McDermott, Jacqueline; Wong, Newton; Kendall, Timothy; Zhang, Yu Zhi; Robinson, Max; Kurian, Kathreena M; Pell, Robert; Shaaban, Abeer M
Journal:
Histopathology
Issue:
Volume 76:Issue 7(2020)
Page Start:
942
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The use of digital pathology and image analysis in clinical trials. (25th March 2019)

Authors:
Pell, Robert; Oien, Karin; Robinson, Max; Pitman, Helen; Rajpoot, Nasir; Rittscher, Jens; Snead, David; Verrill, Clare
Other Names:
Driskell Owen J investigator.; Hall Andy investigator.; James Jacqueline investigator.; Jones Louise J investigator.; Craig Clare investigator.; Sloan Philip investigator.; Thomas Gareth J investigator.; Elliott Philip investigator.; Cheang Maggie investigator.; Rodriguez‐Justo Manuel investigato...
Journal:
Journal of pathology
Issue:
Volume 5:Number 2(2019)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗